{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:41:16Z","timestamp":1787503276095,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015311","name":"Novartis Institutes for BioMedical Research Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.taap.2025.117529","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:25:04Z","timestamp":1755807904000},"page":"117529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["SACF and GILA assays on AML12 cells show limited predictive value for mouse liver genotoxicity"],"prefix":"10.1016","volume":"504","author":[{"given":"Erica","family":"Coratella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Beibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mevion","family":"Oertli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeddine","family":"Elhajouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Libertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.taap.2025.117529_bb0005","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1016\/j.jtha.2024.07.012","article-title":"Adeno-associated viral vector integration: implications for long-term efficacy and safety","volume":"22","author":"Batty","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"16","key":"10.1016\/j.taap.2025.117529_bb0010","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1101\/gad.1938710","article-title":"Nf2\/Merlin controls progenitor homeostasis and tumorigenesis in the liver","volume":"24","author":"Benhamouche","year":"2010","journal-title":"Genes Dev."},{"issue":"22","key":"10.1016\/j.taap.2025.117529_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.taap.2025.117529_bb0020","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","article-title":"Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy","volume":"125","author":"Chandler","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.taap.2025.117529_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/mt.2016.17","article-title":"Genotoxicity in mice following AAV gene delivery: a safety concern for human gene therapy?","volume":"24","author":"Chandler","year":"2016","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.taap.2025.117529_bb0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ymthe.2020.10.018","article-title":"Liver injury increases the incidence of HCC following AAV gene therapy in mice","volume":"29","author":"Dalwadi","year":"2021","journal-title":"Mol. Ther."},{"issue":"23","key":"10.1016\/j.taap.2025.117529_bb0050","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1182\/bloodadvances.2024014111","article-title":"Adeno-associated virus-based gene therapy for hemophilia a and B: a systematic review and meta-analysis","volume":"8","author":"Deshpande","year":"2024","journal-title":"Blood Adv."},{"issue":"5837","key":"10.1016\/j.taap.2025.117529_bb0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV vector integration sites in mouse hepatocellular carcinoma","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.taap.2025.117529_bb0060","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1158\/0008-5472.CAN-09-1135","article-title":"A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice","volume":"69","author":"Dupuy","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2025.117529_bb0065","series-title":"Skysona : EPAR - Product information","author":"EMA\/332184\/2021","year":"2021"},{"issue":"6","key":"10.1016\/j.taap.2025.117529_bb0070","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1053\/j.gastro.2012.08.047","article-title":"Conditional disruption of Axin1 leads to development of liver tumors in mice","volume":"143","author":"Feng","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.taap.2025.117529_bib262","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/mt.2016.52","article-title":"Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients","volume":"24","author":"Gil-Farina","year":"2016","journal-title":"Mol Ther."},{"issue":"4302","key":"10.1016\/j.taap.2025.117529_bb0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1126\/science.560061","article-title":"Primary bioassay of human tumor stem cells","volume":"197","author":"Hamburger","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.taap.2025.117529_bb0085","first-page":"0291","article-title":"AAV for gene therapy in ocular diseases: Progress and prospects","volume":"6","author":"He","year":"2023","journal-title":"Research (Wash D C)"},{"issue":"8","key":"10.1016\/j.taap.2025.117529_bb0090","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/gutjnl-2016-312734","article-title":"TSC1\/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication","volume":"66","author":"Ho","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.taap.2025.117529_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050785","article-title":"Various AAV serotypes and their applications in gene therapy: an overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.taap.2025.117529_bb0100","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","article-title":"A single-cell landscape of high-grade serous ovarian cancer","volume":"26","author":"Izar","year":"2020","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.taap.2025.117529_bb0105","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1158\/1078-0432.CCR-12-0372","article-title":"Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer","volume":"18","author":"Julien","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.taap.2025.117529_bib265","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1053\/j.gastro.2012.02.009","article-title":"Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation","volume":"142","author":"Katz","year":"2012","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1016\/j.taap.2025.117529_bb0115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/j.gastro.2013.01.053","article-title":"Akt and mTORC1 have different roles during liver tumorigenesis in mice","volume":"144","author":"Kenerson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2025.117529_bb0120","doi-asserted-by":"crossref","first-page":"17892","DOI":"10.1038\/srep17892","article-title":"Ultra-sensitive detection of tumorigenic cellular impurities in human cell-processed therapeutic products by digital analysis of soft agar colony formation","volume":"5","author":"Kusakawa","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.taap.2025.117529_bib264","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.32802","article-title":"TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk","volume":"78","author":"Lam","year":"2023","journal-title":"Hepatology."},{"key":"10.1016\/j.taap.2025.117529_bb0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.omtm.2021.09.004","article-title":"Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells","volume":"23","author":"Lemmens","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"10","key":"10.1016\/j.taap.2025.117529_bb0130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.taap.2025.117529_bib263","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4149\/neo_2020_200730N785","article-title":"LncRNA MEG8 plays an oncogenic role in hepatocellular carcinoma progression through miR-367-3p\/14-3-3\u03b6\/TGF\u03b2R1 axis","volume":"68","author":"Lou","year":"2021","journal-title":"Neoplasma."},{"issue":"1","key":"10.1016\/j.taap.2025.117529_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.24653","article-title":"Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss","volume":"55","author":"Morris","year":"2012","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.taap.2025.117529_bb0140","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1128\/JVI.73.7.5438-5447.1999","article-title":"Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver","volume":"73","author":"Nakai","year":"1999","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.taap.2025.117529_bb0145","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.taap.2025.117529_bib261","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat Biotechnol."},{"issue":"6","key":"10.1016\/j.taap.2025.117529_bb0150","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/mt.2012.47","article-title":"Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver","volume":"20","author":"Nowrouzi","year":"2012","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.taap.2025.117529_bb0155","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep.510240508","article-title":"Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249","volume":"24","author":"Oguey","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2025.117529_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117229","article-title":"In vitro NIH3T3 mouse embryonic fibroblast cell model does not predict AAV2 or AAVdj-mediated cell transformation","volume":"495","author":"Qiu","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2025.117529_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nmeth.2331","article-title":"Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer","volume":"10","author":"Ranzani","year":"2013","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.taap.2025.117529_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003441","article-title":"Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis","volume":"9","author":"Riordan","year":"2013","journal-title":"PLoS Genet."},{"issue":"18","key":"10.1016\/j.taap.2025.117529_bb0175","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1073\/pnas.1505979112","article-title":"Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation","volume":"112","author":"Rotem","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.taap.2025.117529_bb0180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.gt.3302243","article-title":"Insertional oncogenesis in gene therapy: how much of a risk?","volume":"11","author":"Sadelain","year":"2004","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.taap.2025.117529_bb0185","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MDNA3-0052-2014","article-title":"Adeno-associated virus as a mammalian DNA vector","volume":"3","author":"Salganik","year":"2015","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.taap.2025.117529_bb0190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2016.01.001","article-title":"Adeno-associated virus (AAV) vectors in cancer gene therapy","volume":"240","author":"Santiago-Ortiz","year":"2016","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.taap.2025.117529_bb0195","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jcyt.2019.10.001","article-title":"Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider","volume":"21","author":"Sato","year":"2019","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.taap.2025.117529_bb0200","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/carcin\/bgr002","article-title":"Hepatomas with activating Ctnnb1 mutations in \u2018Ctnnb1-deficient\u2019 livers: a tricky aspect of a conditional knockout mouse model","volume":"32","author":"Sekine","year":"2011","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.taap.2025.117529_bb0205","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.celrep.2019.08.090","article-title":"Synthetic lethal interaction of SHOC2 depletion with MEK inhibition in RAS-driven cancers","volume":"29","author":"Sulahian","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.taap.2025.117529_bb0210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2011.02.003","article-title":"Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase","volume":"144","author":"Sun","year":"2011","journal-title":"Cell T."},{"issue":"3","key":"10.1016\/j.taap.2025.117529_bb0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/13543784.2024.2313105","article-title":"Duchenne muscular dystrophy: promising early-stage clinical trials to watch","volume":"33","author":"Tang","year":"2024","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.taap.2025.117529_bb0220","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/mt.2014.240","article-title":"Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates","volume":"23","author":"Walia","year":"2015","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.taap.2025.117529_bb0225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"28","key":"10.1016\/j.taap.2025.117529_bb0230","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1073\/pnas.1117032109","article-title":"Induction of hepatocellular carcinoma by in vivo gene targeting","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.taap.2025.117529_bib267","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.hepres.2005.09.026","article-title":"Hepatocyte-specific Pten-deficient mice as a novel model for nonalcoholic steatohepatitis and hepatocellular carcinoma","volume":"33","author":"Watanabe","year":"2005","journal-title":"Hepatol Res."},{"issue":"2","key":"10.1016\/j.taap.2025.117529_bb0235","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1073\/pnas.91.2.674","article-title":"Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha","volume":"91","author":"Wu","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.taap.2025.117529_bb0240","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154515","article-title":"beta-catenin signaling in hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"7522","key":"10.1016\/j.taap.2025.117529_bb0245","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","article-title":"CRISPR-mediated direct mutation of cancer genes in the mouse liver","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.taap.2025.117529_bb0250","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1128\/jvi.71.12.9231-9247.1997","article-title":"Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro","volume":"71","author":"Yang","year":"1997","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.taap.2025.117529_bb0255","first-page":"3650","article-title":"Molecular alterations of the NF2 gene in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"38","author":"Zhang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.taap.2025.117529_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.taap.2025.117529_bib266","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3892\/mmr.2013.1406","article-title":"Expression and significance of PTEN and miR-92 in hepatocellular carcinoma","volume":"7","author":"Zhao","year":"2013","journal-title":"Mol Med Rep."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:29:13Z","timestamp":1779942553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25003059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"alternative-id":["S0041008X25003059"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117529","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SACF and GILA assays on AML12 cells show limited predictive value for mouse liver genotoxicity","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117529"}}